老化のメカニズム

In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an (125)I-labelled DNA-intercalator.

Journal of drug targeting·2011

Epidermal growth factor-DNA conjugate for two-step targeting.

International journal of oncology·2011

Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells.

Gene therapy·2011

Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin.

British journal of cancer·2009

Astatinated trastuzumab, a putative agent for radionuclide immunotherapy of ErbB2-expressing tumours.

Oncology reports·2006

Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1.

Journal of molecular endocrinology·2005

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Modeling Time Cell Neuron-Level Dynamics.

Computational brain & behavior·2026

Valuing Behavioral By-Products: Evolutionary Significance of Neutrally Drifting and Exaptive Cultures in Primates.

American journal of primatology·2026

Environmental Benzene Exposure Induces a Conserved Neutrophil Degranulation Program Across Species.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Transposable element dynamics and regulatory role in sika deer (Cervus nippon) antler development.

Mobile DNA·2026

The impact of prior wake duration on motor wake inertia in different age groups.

Sleep medicine·2026

The emergence of the ectodysplasin pathway.

Open life sciences·2026

関連する実験動画

老化のメカニズム

関連する概念動画

In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an (125)I-labelled DNA-intercalator.

Epidermal growth factor-DNA conjugate for two-step targeting.

Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells.

Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin.

Astatinated trastuzumab, a putative agent for radionuclide immunotherapy of ErbB2-expressing tumours.

Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Modeling Time Cell Neuron-Level Dynamics.

Valuing Behavioral By-Products: Evolutionary Significance of Neutrally Drifting and Exaptive Cultures in Primates.

Environmental Benzene Exposure Induces a Conserved Neutrophil Degranulation Program Across Species.

Transposable element dynamics and regulatory role in sika deer (Cervus nippon) antler development.

The impact of prior wake duration on motor wake inertia in different age groups.

The emergence of the ectodysplasin pathway.

関連する実験動画

老化のメカニズム

関連する概念動画

関連記事